CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Need ways to save money in your budget fast? Check out these quick tips to help you maximize your savings in no time.
20,742 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
A government-contract windfall sparked a sharp rally in Viasat stock. This article breaks down the news, the technolo...
Markets brace for a potential rate move at the July FOMC meeting as JPMorgan Asset Management weighs in on Warsh-era ...
CVS Health is leveraging its vast network to tap into the GLP-1 weight-loss wave. This explainers-backed piece breaks...
As pay-TV declines, Comcast may lean on first-party data to power targeted streaming ads. This article breaks down ho...
Investors scanned the markets as AMC faced dilution concerns that weighed on sentiment. This piece breaks down what h...
A rising chorus of lawmakers is calling for formal investigations into crypto profits tied to a high-profile figure. ...
Retirees approaching 65 must act within a six-month window to secure guaranteed Medigap pricing. Missing the medigap ...
When KD shares surged mid-morning, traders asked if the move reflected real earnings momentum or relief from a scare....
OpenAI has redefined its mission and governance, moving into a for-profit structure and removing safety language from...
The Meta deal lights up new questions about AMD's growth path and dilution risk. This guide breaks down what the 6 gi...
As inflation stays in focus for 2026, investors are rethinking retirement allocations. A diversified commodity ETF of...